ArticleNPJ precision oncology2025
CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancer.
Allison Makovec et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it